Search results
Insider Sale Alert: Moderna Inc [MRNA] – Is it Time to sell? – Knox Daily
Knox Daily· 5 days agoIn a filing, Moderna Inc revealed its Director AFEYAN NOUBAR unloaded Company’s shares for reported $1.66 million on May 01 ’24. In the deal valued at $110.92 per share,15,000 ...
Top Stock Movers Now: TSMC, Moderna, Sweetgreen, and More
Investopedia· 2 days agoU.S. equities were mixed at midday, as the markets reacted to corporate headlines and report showing...
Moderna: FDA Extends RSV Vaccine Review, But No Issues Flagged
Morningstar· 2 days agoModerna on Friday said the Food and Drug Administration won't meet its May 12 target action date for a decision on the company's proposed vaccine for respiratory syncytial ...
Midday movers: Novavax, Nvidia, Sweetgreen rise; Moderna, Yelp fall By Investing.com
Investing.com· 2 days agoMidday movers: Novavax, Nvidia, Sweetgreen rise; Moderna, Yelp fall
Novavax, Nvidia, Sweetgreen rise premarket; Moderna, Yelp fall By Investing.com
Investing.com· 2 days agoNovavax, Nvidia, Sweetgreen rise premarket; Moderna, Yelp fall
Moderna says FDA delaying decision on RSV vaccine approval, shares fall By Investing.com
Investing.com· 2 days agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters via Yahoo Finance· 2 days agoThe U.S. Food and Drug Administration has pushed back its decision on Moderna's respiratory syncytial virus (RSV) vaccine by more than two weeks to the end of this month due ...
Mission Wealth Management LP Acquires New Holdings in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 7 days agoMission Wealth Management LP bought a new position in Moderna, Inc. (NASDAQ:MRNA – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities ...
Moderna’s mRNA dreams meet reality with first post-Covid shot
Boston.com· 3 days agoModerna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion biotech giant and...
Moderna's Options Frenzy: What You Need to Know - Moderna (NASDAQ:MRNA)
Benzinga· 6 days agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Moderna MRNA , and it's something market players shouldn't ignore. Our tracking of public ...